Biprogy Inc.
Biprogy Inc. Fundamental Analysis
Biprogy Inc. (8056.T) shows moderate financial fundamentals with a PE ratio of 13.49, profit margin of 7.68%, and ROE of 19.73%. The company generates $435.9B in annual revenue with moderate year-over-year growth of 9.15%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 74.1/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze 8056.T's fundamental strength across five key dimensions:
Efficiency Score
Excellent8056.T demonstrates superior asset utilization.
Valuation Score
Moderate8056.T shows balanced valuation metrics.
Growth Score
Moderate8056.T shows steady but slowing expansion.
Financial Health Score
Excellent8056.T maintains a strong and stable balance sheet.
Profitability Score
Moderate8056.T maintains healthy but balanced margins.
Key Financial Metrics
Is 8056.T Expensive or Cheap?
P/E Ratio
8056.T trades at 13.49 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, 8056.T's PEG of 3.32 indicates potential overvaluation.
Price to Book
The market values Biprogy Inc. at 2.66 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 6.70 times EBITDA. This is generally considered low.
How Well Does 8056.T Make Money?
Net Profit Margin
For every $100 in sales, Biprogy Inc. keeps $7.68 as profit after all expenses.
Operating Margin
Core operations generate 10.46 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $19.73 in profit for every $100 of shareholder equity.
ROA
Biprogy Inc. generates $10.51 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Biprogy Inc. produces operating cash flow of $63.86B, showing steady but balanced cash generation.
Free Cash Flow
Biprogy Inc. generates strong free cash flow of $59.64B, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $617.22 in free cash annually.
FCF Yield
8056.T converts 13.25% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
13.49
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
3.32
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.66
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.03
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.35
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.60
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.20
vs 25 benchmark
ROA
Return on assets percentage
0.11
vs 25 benchmark
ROCE
Return on capital employed
0.22
vs 25 benchmark
How 8056.T Stacks Against Its Sector Peers
| Metric | 8056.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 13.49 | 34.43 | Better (Cheaper) |
| ROE | 19.73% | 1135.00% | Weak |
| Net Margin | 7.68% | -134663.00% (disorted) | Weak |
| Debt/Equity | 0.35 | 7.92 | Strong (Low Leverage) |
| Current Ratio | 1.60 | 5.77 | Neutral |
| ROA | 10.51% | -310462.00% (disorted) | Strong |
8056.T outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROA, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Biprogy Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
31.80%
Industry Style: Growth, Innovation, High Beta
High GrowthEPS CAGR
50.75%
Industry Style: Growth, Innovation, High Beta
High GrowthFCF CAGR
65.78%
Industry Style: Growth, Innovation, High Beta
High Growth